Citations Report

Clinical Practice : Citations & Metrics Report

Articles published in Clinical Practice have been cited by esteemed scholars and scientists all around the world.

Clinical Practice has got h-index 29, which means every article in Clinical Practice has got 29 average citations.

Following are the list of articles that have cited the articles published in Clinical Practice.

• Benohanian A, 2007. Should local anesthetics be banned during treatment of palmar hyperhidrosis with botulinum toxin A?. Dermatology online journal, 13(3). View at Publisher | View at Google Scholar | View at Indexing
• Benohanian A, Focal hyperhidrosis: choose the therapeutic approach. View at Publisher | View at Google Scholar | View at Indexing
• Corradi M, Spinola M, Petruzzelli S and Kuna P, 2016. High-dose beclometasone dipropionate/formoterol fumarate in fixed-dose combination for the treatment of asthma. Therapeutic Advances in Respiratory Disease, 10(5), pp.492-502. View at Publisher | View at Google Scholar | View at Indexing
•  Watkins RR. Chronic Fatigue Syndrome and the Association With the Human Retrovirus XMRV. Infectious Diseases in Clinical Practice. 2011 Nov 1;19(6):388-91. View at Publisher | View at Google Scholar | View at Indexing
•  Yang Xi, Lin Zenghua, Zhang Yaping. A case report of histiocytic sarcoma and literature review. Journal of Transportation Medicine. 2012;26(1):73-5. View at Publisher | View at Google Scholar | View at Indexing
•  Qian Caifeng. Insulin detemir combined with repaglinide in the treatment of 30 cases of newly diagnosed type 2 diabetes. Clinical observation. Journal of Transportation Medicine. 2012;26(1):76-7. View at Publisher | View at Google Scholar | View at Indexing
•  Mou Lan, Ma Jingdong. Overview of clinical effects and pharmacoeconomic evaluation of basal insulin. Drug Evaluation. 2013(3):16-21. View at Publisher | View at Google Scholar | View at Indexing
• Dong Qijuan. Effectiveness and safety of insulin detemir combined with repaglinide in the treatment of newly diagnosed type 2 diabetes patients. Chinese Journal of Diabetes. 2011;19(8):613-5. View at Publisher | View at Google Scholar | View at Indexing
•  Bae KD. The evolution and value of diphtheria vaccine. KSBB Journal. 2011;26(6):491-504. View at Publisher | View at Google Scholar | View at Indexing
• Webster L, Diva U, Tummala R, Sostek M. Treatment with Naloxegol versus placebo: pain assessment in patients with noncancer pain and opioid?induced constipation. Pain Practice. 2018 Apr;18(4):505-14. View at Publisher | View at Google Scholar | View at Indexing
• Bonafede M, Wilson K, Xue F. Long-term treatment patterns of prophylactic and acute migraine medications and incidence of opioid-related adverse events in patients with migraine. Cephalalgia. 2019 Aug;39(9):1086-98. View at Publisher | View at Google Scholar | View at Indexing
• Holzer P. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?. Current pharmaceutical design. 2012 Dec 1;18(37):6010-20. View at Publisher | View at Google Scholar | View at Indexing
• Fruhwald S, Kainz J. Effect of ICU interventions on gastrointestinal motility. Current opinion in critical care. 2010 Apr 1;16(2):159-64. View at Publisher | View at Google Scholar | View at Indexing
•  Holzer P. Opioid antagonists for prevention and treatment of opioid-induced gastrointestinal effects. Current Opinion in Anesthesiology. 2010 Oct 1;23(5):616-22. View at Publisher | View at Google Scholar | View at Indexing
• Chey WD, Webster L, Sostek M, Lappalainen J, Barker PN, Tack J. Naloxegol for opioid-induced constipation in patients with noncancer pain. New England Journal of Medicine. 2014 Jun 19;370(25):2387-96. View at Publisher | View at Google Scholar | View at Indexing
• Holzer P. Opioid receptors in the gastrointestinal tract. Regulatory peptides. 2009 Jun 5;155(1-3):11-7. View at Publisher | View at Google Scholar | View at Indexing
• Sweetenham JW. Identifying new targets for cancer therapy: the dawn of personalized cancer treatment?. Therapy. 2009 May 1;6(3):291-3. View at Publisher | View at Google Scholar | View at Indexing
• Kim JJ, Rini BI, Hansel DE. Von hippel lindau syndrome. Diseases of DNA Repair. 2010:228-49. View at Publisher | View at Google Scholar | View at Indexing
• Sweetenham JW. Identifying new targets for cancer therapy: the dawn of personalized cancer treatment?. Therapy. 2009 May 1;6(3):291-3. View at Publisher | View at Google Scholar | View at Indexing

• Sinha A and Ewies AAA, 2013. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview. Climacteric, 16(3), pp.305-312.

  View at Publisher | View at Google Scholar

• Palacios S, Cancelo MJ, Castelo-Branco C, González S and Olalla MA, 2012. Recommendations of the Spanish Society of Gynecology and Obstetrics on the prevention and treatment of vaginal atrophy. Progress of Obstetrics and Gynecology, 55 (8), pp. 408-415.

  View at Publisher | View at Google Scholar
• Tolia V. Cutting-edge management of pediatric emergencies. Clinical Practice. 2008 Jul 1;5(4):381. View at Publisher | View at Google Scholar | View at Indexing

• Metro G and Crinò L, 2011. The LUX-Lung clinical trial program of afatinib for non-small-cell lung cancer. Expert review of anticancer therapy, 11(5), pp.673-682.

  View at Publisher | View at Google Scholar

• Metro G and Crinò L, 2012. Advances on EGFR mutation for lung cancer. Translational lung cancer research, 1(1), pp.5-13.

  View at Publisher | View at Google Scholar

• Sweetenham JW, 2009. Identifying new targets for cancer therapy: the dawn of personalized cancer treatment?.

  View at Publisher | View at Google Scholar

• Metro G and Crinò L, 2012. Targeted Therapies for Non-small-Cell Lung Cancer. In Biotargets of Cancer in Current Clinical Practice (pp. 93-114). Humana Press.

  View at Publisher | View at Google Scholar
•  Sweetenham JW. Identifying new targets for cancer therapy: the dawn of personalized cancer treatment?. Therapy. 2009 May 1;6(3):291-3. View at Publisher | View at Google Scholar | View at Indexing
• Djedid R, Tomasi O, Haidara A, Rynkowski M, Lefranc F. Treatment of glioblastomas at the dawn of 2010. Medical review of Brussels. 2009; 30 (5): 496. View at Publisher | View at Google Scholar | View at Indexing
• Li B, Li Y, Tomkiewicz-Raulet C, Dao P, Lietha D, Yen-Pon E, Du Z, Coumoul X, Garbay C, Etheve-Quelquejeu M, Chen H. Design, Synthesis, and Biological Evaluation of Covalent Inhibitors of Focal Adhesion Kinase (FAK) against Human Malignant Glioblastoma. Journal of Medicinal Chemistry. 2020 Oct 29;63(21):12707-24. View at Publisher | View at Google Scholar | View at Indexing
• Zhang Q, Liu X, Li X, Li C, Zhou H, Yan B. Antitumor activity of (2E, 5Z)-5-(2-hydroxybenzylidene)-2-((4-phenoxyphenyl) imino) thiazolidin-4-one, a novel microtubule-depolymerizing agent, in U87MG human glioblastoma cells and corresponding mouse xenograft model. Journal of pharmacological sciences. 2013 Jan 1;122(3):223-31. View at Publisher | View at Google Scholar | View at Indexing
• Bruyère C, Madonna S, Van Goietsenoven G, Mathieu V, Dessolin J, Kraus JL, Lefranc F, Kiss R. JLK1486, a Bis 8-hydroxyquinoline-substituted benzylamine, displays cytostatic effects in experimental gliomas through MyT1 and STAT1 activation and, to a lesser extent, PPARγ activation. Translational oncology. 2011 Jun 1;4(3):126-IN7. View at Publisher | View at Google Scholar | View at Indexing
• Neyns B, D'haeseleer M, Rogiers A, Van de Cauter J, Chaskis C, Michotte A, Strik H. The role of cytotoxic drugs in the treatment of central nervous system gliomas. Acta neurologica belgica. 2010;110(1):1-4. View at Publisher | View at Google Scholar | View at Indexing
• Bruyère C, Abeloos L, Lamoral-Theys D, Senetta R, Mathieu V, Le Mercier M, Kast RE, Cassoni P, Vandenbussche G, Kiss R, Lefranc F. Temozolomide modifies caveolin-1 expression in experimental malignant gliomas in vitro and in alive. Translational oncology. 2011 Apr 1; ??4 (2): 92-100. View at Publisher | View at Google Scholar | View at Indexing
• Putra H, Journalist YD, Sayoeti Y. Medical management of gastrointestinal disease. Andalas Health Journal. 2019 May 14;8(2):407-18. View at Publisher | View at Google Scholar | View at Indexing
•  Sweetenham JW. Identifying new targets for cancer therapy: the dawn of personalized cancer treatment?. Therapy. 2009 May 1;6(3):291-3. View at Publisher | View at Google Scholar | View at Indexing
• Guolla CK, Chan K. Hemolytic Anemia. Essentials of Pediatric Emergency Medicine. 2018 Sep 12:178-80. View at Publisher | View at Google Scholar | View at Indexing
• Ciprandi G, 2010. Clinical utility and patient adherence with ebastine for allergic rhinitis. Patient preference and adherence, 4, p.389. View at Publisher | View at Google Scholar | View at Indexing
•   Nwaopara AU, Allagoa EL. Bilateral Orchidopexy in a Hypochondriacal (Somatic Symptom Disorder) Patient and Determination of Fitness for Bilateral Orchidectomy. Case reports in psychiatry. 2016 Jul 11;2016.   View at Publisher | View at Google Scholar | View at Indexing
•   Chopra S, Khan R. Delusional Disorder. Medscape reference. Drugs, Diseases & Procedures. 2011 Mar 10.   View at Publisher | View at Google Scholar | View at Indexing
•  Agrawal V, Giri C, Solomon RJ. The effects of glucose-lowering therapies on diabetic kidney disease. Current diabetes reviews. 2015 Sep 1;11(3):191-200. View at Publisher | View at Google Scholar | View at Indexing
•  Rao BB, Bhattacharya A, Agrawal V. Renal outcomes of bariatric surgery in obese adults with diabetic kidney disease. Journal of nephrology. 2014 Aug;27(4):361-70. View at Publisher | View at Google Scholar | View at Indexing
• McCullough PA, Ali S. Cardiac and renal function in patients with type 2 diabetes who have chronic kidney disease: potential effects of bardoxolone methyl. Drug design, development and therapy. 2012;6:141. View at Publisher | View at Google Scholar | View at Indexing
• McCullough PA, Steigerwalt S, Tolia K, Chen SC, Li S, Norris KC, Whaley-Connell A, Keep Investigators. Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP). Current diabetes reports. 2011 Feb 1;11(1):47-55. View at Publisher | View at Google Scholar | View at Indexing
• Valero A, Izquierdo I, Kowalski ML, Scadding GK, Bousquet J, Mullol J. Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis. Allergy, Asthma & Clinical Immunology. 2020 Dec;16(1):1-9. View at Publisher | View at Google Scholar | View at Indexing
• Sybil AJ. Chronic allergic rhinitis in children - a problem to be solved. Stand. Med. Ped. 2013; 10 (5): 613-23. View at Publisher | View at Google Scholar | View at Indexing
• Molina M, Cisteró A, Martínez RA, Montero J, García-González JJ, Serra J, De La Torre F, Izquierdo I. Rupatadine 10 mg in adolescent and adult symptom relief of perennial allergic rhinitis. Clinical Practice. 2010 Jul 1;7(4):429. View at Publisher | View at Google Scholar | View at Indexing
• Compalati E, Canonica GW. Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. Current medical research and opinion. 2013 Nov 1;29(11):1539-51. View at Publisher | View at Google Scholar | View at Indexing
• Valero A, Izquierdo I, Giralt J, Bartra J, del Cuvillo A, Mullol J. Rupatadine improves nasal symptoms, quality of life (ESPRINT-15) and severity in a subanalysis of a cohort of Spanish allergic rhinitis patients. J Investig Allergol Clin Immunol. 2011 Jan 1;21(3):229-35. View at Publisher | View at Google Scholar | View at Indexing
• Mullol J, Bousquet J, Bachert C, Canonica GW, Giménez?Arnau A, Kowalski ML, Simons FE, Maurer M, Ryan D, Scadding G. Update on rupatadine in the management of allergic disorders. Allergy. 2015 Jan;70:1-24. View at Publisher | View at Google Scholar | View at Indexing
•  Mankin HJ, Mankin KP, Harmon DC. Liposarcoma: a soft tissue tumor with many presentations. Musculoskeletal surgery. 2014 Dec 1;98(3):171-7. View at Publisher | View at Google Scholar | View at Indexing